Sex-related impact on clinical outcome of everolimus-eluting versus bare-metal stents in ST-segment myocardial infarction. insights from the EXAMINATION trial;Influencia del sexo en los resultados clínicos de los stents liberadores de everolimus en comparación con los stents metálicos sin recubrimiento en el infarto agudo de miocardio con elevación del segmento ST. Perspectivas del ensayo EXAMINATION

Revista Espanola de Cardiologia

Volumn 68, Issue 5, 2015, Pages 382-389

  Regueiro, Ander ^a   Fernández Rodríguez, Diego ^a   Brugaletta, Salvatore ^a   Martín Yuste, Victoria ^a   Masotti, Monica ^a   Freixa, Xavier ^a   Cequier, Ángel ^b   Íñiguez, Andrés ^c   Serruys, Patrick W ^d   Sabaté, Manel ^a  

^a HOSPITAL CLÍNIC   (Spain)

^b HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^c UNIVERSITY HOSPITAL COMPLEX OF VIGO   (Spain)

^d ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Myocardial infarction; Sex; Stent

Indexed keywords

EVEROLIMUS; IMMUNOSUPPRESSIVE AGENT; RAPAMYCIN;

ARTICLE; BARE METAL STENT; COMPARATIVE EFFECTIVENESS; CONTROLLED STUDY; EVEROLIMUS ELUTING CORONARY STENT; FEMALE; FOLLOW UP; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PREVALENCE; RECURRENT DISEASE; SEX DIFFERENCE; SMOKING; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; AGED; ANALOGS AND DERIVATIVES; CLINICAL TRIAL; DRUG ELUTING STENT; ELECTROCARDIOGRAPHY; MIDDLE AGED; MULTICENTER STUDY; MYOCARDIAL INFARCTION; PATHOPHYSIOLOGY; PERCUTANEOUS CORONARY INTERVENTION; PROCEDURES; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

AGED; DRUG-ELUTING STENTS; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PERCUTANEOUS CORONARY INTERVENTION; SEX FACTORS; SIROLIMUS; TREATMENT OUTCOME;

EID: 84928290611     PISSN: 03008932     EISSN: 15792242     Source Type: Journal    
DOI: 10.1016/j.recesp.2014.04.023     Document Type: Article

References (32)

1. V. Vaccarino, H.M. Krumholz, L.F. Berkman, and R.I. Horwitz Sex differences in mortality after myocardial infarction Circulation 91 1995 1861 1871
2. F. Alfonso, R. Hernández, C. Bañuelos, A. Fernández-Ortíz, J. Escaned, and M. Sabaté Initial results and long-term clinical and angiographic outcome of coronary stenting in women Am J Cardiol 86 2000 1380 1383
3. J. Mehilli, A. Kastrati, H. Bollwein, A. Dibra, H. Schühlen, and J. Dirschinger Gender and restenosis after coronary artery stenting Eur Heart J 24 2003 1523 1530
4. R. Kornowski, H. Vaknin-Assa, A. Assali, E.I. Lev, A. Porter, and A. Battler A comparative analysis of major clinical outcomes with drug-eluting stents versus bare metal stents in male vs. female patients EuroIntervention 7 2012 1051 1059
5. G.G. Stefanini, U. Baber, S. Windecker, M.C. Morice, S. Sartori, and M.B. Leon Safety and efficacy of drug-eluting stents in women: a patient-level pooled analysis of randomised trials Lancet 382 2013 1879 1888
6. M. Sabaté, P. Jiménez-Quevedo, D.J. Angiolillo, J.A. Gómez-Hospital, F. Alfonso, R. Hernández-Antolín DIABETES Investigators Randomized comparison of sirolimus-eluting stent vs. standard stent for percutaneous coronary revascularization in diabetic patients: the diabetes and sirolimus-eluting stent (DIABETES) trial Circulation 112 2005 2175 2183
7. M.C. Morice, P.W. Serruys, J.E. Sousa, J. Fajadet, E. Ban Hayashi, and M. Perin A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization N Engl J Med 346 2002 1773 1780
8. G.W. Stone, S.G. Ellis, D.A. Cox, J. Hermiller, C. O'Shaughnessy, and J.T. Mann A polymer based, paclitaxel-eluting stent in patients with coronary artery disease N Engl J Med 350 2004 221 231
9. J.W. Moses, M.B. Leon, J.J. Popma, P.J. Fitzgerald, D.R. Holmes, and C. O'Shaughnessy Sirolimus-eluting stents vs. standard stents in patients with stenosis in a native coronary artery N Engl J Med 349 2003 1315 1323
10. M. Sabate, A. Cequier, A. Iñiguez, A. Serra, R. Hernandez-Antolin, and V. Mainar Everolimus-eluting stent vs. bare-metal stent in ST-segment elevation myocardial infarction (EXAMINATION): 1 year results of a randomised controlled trial Lancet 380 2012 1482 1490
11. M. Sabaté, S. Brugaletta, A. Cequier, A. Iñiguez, A. Serra, and R. Hernández-Antolín The EXAMINATION trial (Everolimus-Eluting Stents Versus Bare-Metal Stents in ST-Segment Elevation Myocardial Infarction): 2-year results from a multicenter randomized controlled trial JACC Cardiovasc Interv 7 2014 64 71
12. L. Räber, H. Kelbæk, M. Ostojic, A. Baumbach, D. Heg, and D. Tüller Effect of biolimus-eluting stents with biodegradable polymer vs bare-metal stents on cardiovascular events among patients with acute myocardial infarction: The COMFORTABLE AMI randomized trial JAMA 308 2012 777 787
13. M. Sabaté, A. Cequier, A. Iñiguez, A. Serra, R. Hernández-Antolín, and V. Mainar Rationale and design of the EXAMINATION trial: a randomised comparison between everolimus-eluting stents and cobalt-chromium bare-metal stents in ST-elevation myocardial infarction EuroIntervention 7 2011 977 984
14. P. Vranckx, D.E. Cutlip, R. Mehran, P.P. Kint, S. Silber, and S. Windecker Myocardial infarction adjudication in contemporary all-comer stent trials: balancing sensitivity and specificity. Addendum to the historical MI definitions used in stent studies EuroIntervention 5 2010 871 874
15. D.E. Cutlip, S. Windecker, R. Mehran, A. Boam, D.J. Cohen, and G.A. Van Es Clinical end points in coronary stent trials: a case for standardized definitions Circulation 115 2007 2344 2351
16. K.A. Skelding, G. Boga, J. Sartorius, G.C. Wood, P.B. Berger, and V.H. Mascarenhas Frequency of coronary angiography and revascularization among men and women with myocardial infarction and their relationship to mortality at one year: an analysis of the Geisinger myocardial infarction cohort J Interv Cardiol 26 2013 14 21
17. T.E. Pain, D.A. Jones, K.S. Rathod, S.M. Gallagher, C.J. Knight, and A. Mathur Influence of female sex on long-term mortality after acute coronary syndromes treated by percutaneous coronary intervention: a cohort study of 7304 patients Coron Artery Dis 24 2013 183 190
18. C. Nazzal, and F.T. Alfonso Las mujeres jóvenes en Chile tienen elevado riesgo de muerte intrahospitalaria por infarto de miocardio Rev Esp Cardiol 66 2013 104 109
19. G. De Luca, M. Verdoia, M.T. Dirksen, C. Spaulding, H. Kelbæk, and M. Schalij Gender-related differences in outcome after BMS or DES implantation in patients with ST-segment elevation myocardial infarction treated by primary angioplasty: Insights from the DESERT cooperation Atherosclerosis 230 2013 12 16
20. S.T. Nauta, J.W. Deckers, R.T. Van Domburg, and K.M. Akkerhuis Gender-related trends in mortality in hospitalized men and women after myocardial infarction between 1985 and 2008: equal benefit for women and men Circulation 126 2012 2184 2189
21. J.S. Berger, L. Elliot, D. Gallup, M. Roe, C.B. Granger, and P.W. Amstrong Sex differences in mortality following acute coronary syndromes JAMA 302 2009 874 882
22. R. Vidal-Pérez, F. Otero-Raviña, J.L. Gómez Vázquez, J.A. Santos Rodríguez, C. De Frutos De Marcos, and J.R. González-Juanatey Cardiopatía isquémica en la mujer. Datos del estudio CIBAR Rev Esp Cardiol 65 2012 1056 1058
23. C. Milcent, B. Dormont, I. Durand-Zaleski, and P.G. Steg Gender differences in hospital mortality and use of percutaneous coronary intervention in acute myocardial infarction Circulation 115 2007 833 839
24. F. Alfonso, M.H. Tayebjee, and G.Y.H. Lip Restenosis after coronary stenting: the 'gender paradox' Eur Heart J 24 2003 2239
25. A.K. Jacobs, S.F. Kelsey, M.M. Brooks, D.P. Faxon, B.R. Chaitman, and V. Bittner Better outcome for women compared with men undergoing coronary revascularization: a report from the bypass angioplasty revascularization investigation (BARI) Circulation 98 1998 1279 1285
26. D. Nakatani, J. Ako, J.A. Tremmel, K. Waseda, H. Otake, and B.K. Koo Sex differences in neointimal hyperplasia following endeavor zotarolimus-eluting stent implantation Am J Cardiol 108 2011 912 917
27. H. Okura, M. Nakamura, J. Kotani, K. Kozuma Taxus Japan Postmarket Surveillance Study Taxus-Pms Investigators Gender-specific outcome after paclitaxel-eluting stent implantation in Japanese patients with coronary artery disease; sub-analysis of the Japan TAXUS Express2 post-marketing survey Circ J 77 2013 1430 1435
28. E. Solinas, E. Nikolsky, A.J. Lansky, A.J. Kirtane, M.C. Morice, and J.J. Popma Gender-specific outcomes after sirolimus-eluting stent implantation J Am Coll Cardiol 50 2007 2111 2116
29. TM everolimus-eluting coronary stent system: clinical and angiographic results from the SPIRIT III randomized trial Catheter Cardiovasc Interv 74 2009 719 727
30. J. Ruiz-García, A. Lerman, G. Weisz, A. Maehara, G.S. Mintz, and M. Fahy Age- and gender-related changes in plaque composition in patients with acute coronary syndrome: the PROSPECT study EuroIntervention 8 2012 929 938
31. S.S. Anand, C.C. Xie, S. Mehta, M.G. Franzosi, C. Joyner, and S. Chrolavicius Differences in the management and prognosis of women and men who suffer from acute coronary syndromes J Am Coll Cardiol 46 2005 1845 1851
32. G.W. Stone, A.J. Lansky, S.J. Pocock, B.J. Gersh, G. Dangas, and S.C. Wong Paclitaxel-eluting stents versus bare-metal stents in acute myocardial infarction N Engl J Med 360 2009 1946 1959